BCL2 and fatty liver disease: The trial revealed that, in all stages of liver steatosis, the proapoptotic proteins p53 and Bax are increasingly expressed in hepatocytes, and the antagonistic protein Bcl-2 is diminished, especially in normal hepatocytes.